netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Results

Looking for Secukinumab found 12 matches
Open monograph to display formulary status BNF Category
  Secukinumab  (Cosentyx®) Musculoskeletal and joint diseases - Cytokine modulators - 10.01.03
  Secukinumab  (Cosentyx®) Skin - Drugs affecting the immune response - 13.05.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section LSCMMG: Secukinumab (Cosentyx▼) NMR (13.05.03)
link in drug section NICE TA350: Secukinumab for treating moderate to severe plaque psoriasis (13.05.03)
link in drug section NICE TA407: Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors (10.01.03)
link in drug section NICE TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs (13.05.03)
link in drug section NICE TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs (10.01.03)
link in drug section NICE TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs (10.01.03)
link in drug section NICE TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs (13.05.03)
link in drug section NICE TA719: Secukinumab for treating non-radiographic axial spondyloarthritis (10.01.03)
link in drug section NICE TA734: Secukinumab for treating moderate to severe plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA935: Secukinumab for treating moderate to severe hidradenitis suppurativa (13.05.03)




Document Library Items Found
Document links New Medicine Reviews (Secukinumab (Cosentyx▼) NMR)

 
netFormulary